On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Established in 2014 as one of the nation’s first programs focused on meeting the complex health needs of underserved communities and marginalized populations, the Allegheny Health Network’s Center for Inclusion Health has grown in the Western Pennslyvania region to provide coordinated and compassionate care delivery using evidence-based interventions.
The Center for Inclusion Health provides a myriad of health services that address disparities in access for mental health, homeless care, transgender care, and addiction medicine, as well as social determinants of health such as food insecurity and housing challenges.
On this episode of Managed Care Cast, we speak with the Division Chief of the Center for Inclusion Health, Elizabeth Cuevas, MD, a board-certified internal medicine physician, who speaks on the major health issues affecting patient outcomes in marginalized communities, the importance of community-level partnerships to identify and address these challenges, and opportunities for growth in managing these populations.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More